Skip Navigation


NDT Advance Access originally published online on September 12, 2006
Nephrology Dialysis Transplantation 2007 22(2):661-662; doi:10.1093/ndt/gfl533
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/2/661    most recent
gfl533v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Buus, N. H.
Right arrow Articles by Jensen, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buus, N. H.
Right arrow Articles by Jensen, J. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Severe intravascular haemolysis and acute renal failure following intravenous administration of iron dextran

Email: nhbuus@dadlnet.dk

The first 10% of the full text of this article appears below.

Sir,

Parenteral administration of iron is occasionally required for treating iron deficiency anaemia in patients with intolerable side effects to, or impaired absorption of, oral iron preparations. However, intravenous administration of iron preparations, as opposed to oral iron, carries a risk of serious adverse reactions [1–3]; the use of iron dextran has especially been associated with allergic reactions [4,5]. Severe haematological adverse reactions to parental iron administration have not been previously published. We . . . [Full Text of this Article]

Niels Henrik Buus and Jens Dam Jensen

Department of Renal Medicine
Aarhus University Hospital
Denmark


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin Med ResHome page
A. Hayat
Safety Issues With Intravenous Iron Products in the Management of Anemia in Chronic Kidney Disease
Clin. Med. Res., December 1, 2008; 6(3-4): 93 - 102.
[Abstract] [Full Text] [PDF]